145 related articles for article (PubMed ID: 38697102)
1. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
Bulcaen M; Kortleven P; Liu RB; Maule G; Dreano E; Kelly M; Ensinck MM; Thierie S; Smits M; Ciciani M; Hatton A; Chevalier B; Ramalho AS; Casadevall I Solvas X; Debyser Z; Vermeulen F; Gijsbers R; Sermet-Gaudelus I; Cereseto A; Carlon MS
Cell Rep Med; 2024 May; 5(5):101544. PubMed ID: 38697102
[TBL] [Abstract][Full Text] [Related]
2. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
3. Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.
King NE; Suzuki S; Barillà C; Hawkins FJ; Randell SH; Reynolds SD; Stripp BR; Davis BR
Hum Gene Ther; 2020 Sep; 31(17-18):956-972. PubMed ID: 32741223
[TBL] [Abstract][Full Text] [Related]
4. Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor.
Amistadi S; Maule G; Ciciani M; Ensinck MM; De Keersmaecker L; Ramalho AS; Guidone D; Buccirossi M; Galietta LJV; Carlon MS; Cereseto A
Mol Ther; 2023 Jun; 31(6):1647-1660. PubMed ID: 36895161
[TBL] [Abstract][Full Text] [Related]
5. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.
Li C; Liu Z; Anderson J; Liu Z; Tang L; Li Y; Peng N; Chen J; Liu X; Fu L; Townes TM; Rowe SM; Bedwell DM; Guimbellot J; Zhao R
PLoS One; 2023; 18(11):e0295009. PubMed ID: 38019847
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
[TBL] [Abstract][Full Text] [Related]
7. Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction.
Suzuki S; Crane AM; Anirudhan V; Barillà C; Matthias N; Randell SH; Rab A; Sorscher EJ; Kerschner JL; Yin S; Harris A; Mendel M; Kim K; Zhang L; Conway A; Davis BR
Mol Ther; 2020 Jul; 28(7):1684-1695. PubMed ID: 32402246
[TBL] [Abstract][Full Text] [Related]
8. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus.
Vaidyanathan S; Baik R; Chen L; Bravo DT; Suarez CJ; Abazari SM; Salahudeen AA; Dudek AM; Teran CA; Davis TH; Lee CM; Bao G; Randell SH; Artandi SE; Wine JJ; Kuo CJ; Desai TJ; Nayak JV; Sellers ZM; Porteus MH
Mol Ther; 2022 Jan; 30(1):223-237. PubMed ID: 33794364
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing for Cystic Fibrosis: Identification of Drugs That Induce CFTR-Independent Fluid Secretion in Nasal Organoids.
Rodenburg LW; Delpiano L; Railean V; Centeio R; Pinto MC; Smits SMA; van der Windt IS; van Hugten CFJ; van Beuningen SFB; Rodenburg RNP; van der Ent CK; Amaral MD; Kunzelmann K; Gray MA; Beekman JM; Amatngalim GD
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293514
[TBL] [Abstract][Full Text] [Related]
10. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
Bednarski C; Tomczak K; Vom Hövel B; Weber WM; Cathomen T
PLoS One; 2016; 11(8):e0161072. PubMed ID: 27526025
[TBL] [Abstract][Full Text] [Related]
11. In vivo editing of lung stem cells for durable gene correction in mice.
Sun Y; Chatterjee S; Lian X; Traylor Z; Sattiraju SR; Xiao Y; Dilliard SA; Sung YC; Kim M; Lee SM; Moore S; Wang X; Zhang D; Wu S; Basak P; Wang J; Liu J; Mann RJ; LePage DF; Jiang W; Abid S; Hennig M; Martinez A; Wustman BA; Lockhart DJ; Jain R; Conlon RA; Drumm ML; Hodges CA; Siegwart DJ
Science; 2024 Jun; 384(6701):1196-1202. PubMed ID: 38870301
[TBL] [Abstract][Full Text] [Related]
12. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
[TBL] [Abstract][Full Text] [Related]
13. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
[TBL] [Abstract][Full Text] [Related]
14. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.
Schwank G; Koo BK; Sasselli V; Dekkers JF; Heo I; Demircan T; Sasaki N; Boymans S; Cuppen E; van der Ent CK; Nieuwenhuis EE; Beekman JM; Clevers H
Cell Stem Cell; 2013 Dec; 13(6):653-8. PubMed ID: 24315439
[TBL] [Abstract][Full Text] [Related]
15. Rewriting CFTR to cure cystic fibrosis.
Maule G; Ensinck M; Bulcaen M; Carlon MS
Prog Mol Biol Transl Sci; 2021; 182():185-224. PubMed ID: 34175042
[TBL] [Abstract][Full Text] [Related]
16. A functional CFTR assay using primary cystic fibrosis intestinal organoids.
Dekkers JF; Wiegerinck CL; de Jonge HR; Bronsveld I; Janssens HM; de Winter-de Groot KM; Brandsma AM; de Jong NW; Bijvelds MJ; Scholte BJ; Nieuwenhuis EE; van den Brink S; Clevers H; van der Ent CK; Middendorp S; Beekman JM
Nat Med; 2013 Jul; 19(7):939-45. PubMed ID: 23727931
[TBL] [Abstract][Full Text] [Related]
17. β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.
Vijftigschild LA; Berkers G; Dekkers JF; Zomer-van Ommen DD; Matthes E; Kruisselbrink E; Vonk A; Hensen CE; Heida-Michel S; Geerdink M; Janssens HM; van de Graaf EA; Bronsveld I; de Winter-de Groot KM; Majoor CJ; Heijerman HG; de Jonge HR; Hanrahan JW; van der Ent CK; Beekman JM
Eur Respir J; 2016 Sep; 48(3):768-79. PubMed ID: 27471203
[TBL] [Abstract][Full Text] [Related]
18.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
19. Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis.
Liu Z; Anderson JD; Deng L; Mackay S; Bailey J; Kersh L; Rowe SM; Guimbellot JS
Genes (Basel); 2020 May; 11(6):. PubMed ID: 32485957
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing for Cystic Fibrosis.
Wang G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
